AG003OJX

611-75-6 | 2,4-Dibromo-6-[(cyclohexyl-methyl-amino)-methyl]-phenylamine

AG003OJX

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

• mg
• g
• kg
• ml
• L

No data

• mg
• g
• kg
• ml
• L

No data

No data

Inquire

CAS Number	611-75-6
Catalog Number	AG003OJX(AGN-PC-0SZ64A)
Chemical Name	2,4-Dibromo-6-[(cyclohexyl-methyl-amino)-methyl]-phenylamine
EC Number	210-280-8
IUPAC Name	2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline;hydrochloride
InChI	InChI=1S/C14H20Br2N2.ClH/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17;/h7-8,12H,2-6,9,17H2,1H3;1H
InChI Key	UCDKONUHZNTQPY-UHFFFAOYSA-N
MDL Number	MFCD00056626
Molecular Formula	C14H21Br2ClN2
Molecular Weight	412.5909
NSC Number	758383
SMILES	Nc1c(cc(cc1Br)Br)CN(C)C2CCCCC2.[H]Cl
UNII	YC2ZOM3Z8V
Synonyms	Aparsonin, BC, Bromhexin, Bisolvon, Bromhexin, Bromhexin BC, Bromhexin Berlin Chemie, Bromhexin Berlin-Chemie, Bromhexin BerlinChemie, Bromhexin ratiopharm, bromhexin von ct, Bromhexin-ratiopharm, Bromhexine, Bromhexine Hydrochloride, Bromhexine Monohydrochloride, Bromhexine, Famel, Bromhexinratiopharm, Brotussol, ct, bromhexin von, Darolan, Dur Elix, Dur-Elix, DurElix, Famel Bromhexine, Flegamin, Flubron, Hustentabs ratiopharm, Hustentabs-ratiopharm, Hustentabsratiopharm, Hydrochloride, Bromhexine, Monohydrochloride, Bromhexine, Mucohexine, NA 274, NA-274, NA274, Quentan, Tesacof, von ct, bromhexin, Bromhexine hydrochloride, 611-75-6, Bromhexine HCl, Auxit, Bisolvon, Bromohexine hydrochloride, Broncokin, Viscolyt, Bromhexine chloride, Quentan, UNII-YC2ZOM3Z8V, Bromhexine (hydrochloride), Bromohexine monohydrochloride, 2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrochloride, YC2ZOM3Z8V, CHEBI:31303, MFCD00056626, NCGC00095005-01, AK163668, 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine hydrochloride, 2-Amino-N-cyclohexyl-3,5-dibromo-N-methylbenzylamine hydrochloride, N-(2-Amino-3,5-dibromobenzyl)-N-methyl-cyclohexylammonium chloride, N-Cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)ammonium chloride, NA 274, C14H21Br2ClN2, DSSTox_CID_25886, DSSTox_RID_81200, DSSTox_GSID_45886, Q-200754, Bromessina, 2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline hydrochloride, N-(2-Amino-3,5-dibromobenzyl)-N-methylcyclohexylamine hydrochloride, CAS-611-75-6, Bisolvon hydrochloride, NA-274, Bromihexine hydrochloride, Ophtolsol, Ophtosol, [(2-amino-3,5-dibromophenyl)methyl]cyclohexylmethylamine, chloride, 2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline;hydrochloride, 2,4-dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline hydrochloride, SR-05000001825, Bisolvon (TN), 2,4-Dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline (HCl), BROMBENZONIUM, AC1NWAVG, bromhexine-hydrochloride, SCHEMBL99613, Bromohexine Hydrochloride,(S), SPECTRUM1503107, CHEMBL1319139, DTXSID0045886, CTK8E6718, HY-B0372A, KS-00000KNR, AOB5798, UCDKONUHZNTQPY-UHFFFAOYSA-N, HMS1922E19, Pharmakon1600-01503107, Tox21_111385, CB0192, CCG-39304, NSC758383, s2060, SBB001448, AKOS015906433, Tox21_111385_1, AC-6857, AN-9584, API0025210, Bromhexine hydrochloride (JP17/USAN), CS-2430, KS-5253, MCULE-9140626069, NSC-758383, NCGC00095005-02, NCGC00178520-03, BC203110, SC-46511, ST007548, Bromhexine hydrochloride, >=98.0% (AT), AB0011975, AB1009382, AX8034291, TC-063551, B4054, Bromhexine hydrochloride, analytical standard, FT-0603492, ST24038612, SW199599-2, D01778, J10434, 611B756, C-21938, SR-05000001825-2, Bromhexine Hydrochloride 1.0 mg/ml in Methanol (as free base), N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexanaminium chloride, 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzenemethanamine Hydrochloride, Bromhexine hydrochloride, European Pharmacopoeia (EP) Reference Standard, N-Cyclohexyl-N-methyl-N-(2-amino-3,5-dibromobenzyl)ammonium chloride, 3,5-dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha,2-diamine monohydrochloride, 3,5-Dibromo-N|A-cyclohexyl-N|A-methyltoluene-|A,2-diamine Monohydrochloride, Bromhexine for system suitability, European Pharmacopoeia (EP) Reference Standard, Bromhexine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine hydrochloride; N-(2-Amino-3,5-dibromobenzyl)-N-methylcyclohexylamine hydrochloride, Lisomucin, bromhexine, Bromessina [Italian], BROMFENAC SODIUM, C14H20Br2N2.ClH, Bromhexine hydrochloride 100g, EINECS 210-280-8, Bromhexine hydrochloride [USAN:JAN], C14-H20-Br2-N2.Cl-H, CID5702220, CS-O-00976, B1899, Benzylamine, 2-amino-N-cyclohexyl-3,5-dibromo-N-methyl-, hydrochloride, Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, monohydrochloride, 3,5-Dibromo-N(sup alpha)-cyclohexyl-N(sup alpha)-methyltoluene-alpha,2-diamine monohydrochloride, Bencenometanamina, 2-amino-3,5-dibromo-N-ciclohexil-N-metil-, clorhidrato de (1:1), 1978-39-8, Toluene-.alpha.,2-diamine, 3,5-dibromo-N.alpha.-cyclohexyl-N.alpha.-methyl-, monohydrochloride, Toluene-alpha,2-diamine, 3,5-dibromo-N(sup alpha)-cyclohexyl-N-(sup alpha)-methyl-, monohydrochloride,

Complexity	256
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	411.974g/mol
Formal Charge	0
Heavy Atom Count	19
Hydrogen Bond Acceptor Count	2
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	412.594g/mol
Monoisotopic Mass	409.976g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	29.3A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number